GZMB and chronic myelogenous leukemia, BCR-ABL1 positive: This also agrees with our observations, which showed that NKG2D blockade did not completely suppress GzmB production, implying that CML-RAE-1γ-Dex boosted NK-cell function in a partly NKG2D-dependent manner (Fig. 4a).